Results 241 to 250 of about 681,701 (308)

In Vivo Evaluation of Efficacy and Safety of Oxygen-Supplemented Accelerated Scleral Cross-Linking Over Time in Young Rabbits. [PDF]

Transl Vis Sci Technol
Ben Hilal H, Zhang J, Liu X, Chen P, Han P, Yan L, Jiang Z, Wang C, Li X, Gao Z, Chen W.   +10 more
europepmc   +1 more source

A Depolarizing Leak in Sodium Bicarbonate Cotransporter NBCe1 Causes Brain Edema

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives SLC4A4 encodes electrogenic sodium bicarbonate cotransporter NBCe1, prominently expressed in kidney and brain. Recessive loss‐of‐function variants in SLC4A4 cause proximal renal tubular acidosis, no brain edema. In the brain, NBCe1 is expressed by astrocytes, where it regulates pH and mediates astrocyte volume changes.
Quinty Bisseling, Mark D. Parker, Sven Kerst, Richard A. Pasternack, Jacob Tondreau, Marjolein Breur, Gemma M. van Rooijen‐van Leeuwen, Davide Tonduti, Ettore Salsano, Alejandra Darling, Joanna A. E. van Wijk, Susanna Törnroth‐Horsefield, Marianna Bugiani, Petra J. W. Pouwels, Quinten Waisfisz, Marjo S. van der Knaap, Rogier Min   +16 more
wiley   +1 more source

Synthesis of Bioconjugation Reagents for Use in Covalent Cross-Linking of Proteins by Azide-Alkyne Cycloaddition. [PDF]

Molecules
Suhorepec N, Ciber L, Grošelj U, Petek N, Štefane B, Novinec M, Svete J.   +6 more
europepmc   +1 more source

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

Annals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold, Krzysztof W. Selmaj, Regina Berkovich, Jeffrey A. Cohen, Giancarlo Comi, Eva K. Havrdová, James K. Sheffield, Hetal Desai, Chun‐Yen Cheng, Jon V. Riolo, Andrew Thorpe, Erik DeBoer, Bruce A. C. Cree   +12 more
wiley   +1 more source

Can Insulin Drops Accelerate Corneal Healing After Corneal Cross-Linking? A Preliminary Case Series. [PDF]

Medicina (Kaunas)
Bagatin F, Vukojević A, Ranđelović K, Radman I, Iveković R, Lacmanović Lončar V, Petric Vicković I, Vatavuk Z.   +7 more
europepmc   +1 more source

P450 Cyptide Synthase KwwB Catalyzes Trp-C5-Trp-N1 Cross-Linking and Accepts Diverse Precursor Peptides. [PDF]

Org Lett
Haedar JR, Kumari GS, Kiselov V, Romanuks V, Smits G, Donadio S, Phan CS.   +6 more
europepmc   +1 more source

In-situ cross-linking mass spectrometry reveals compartment-specific proteasomal interactions and structural heterogeneity. [PDF]

Nat Commun
Zhao L, Zhao R, Gong Z, Liang F, Zhao N, Zhong B, Liu M, Zhang Y, Zhao Q, Zhang L, Tang C.   +10 more
europepmc   +1 more source

Cross-Linking PEG Microgels with Mesoporous Organosilica Nanoparticles to Engineer Microporous Annealed Particle Scaffold Properties. [PDF]

ACS Omega
Zuidema JM, Ajò A, Carofiglio M, De Cola L.   +3 more
europepmc   +1 more source

Bridging gaps in corneal ulcer management: Can photoactivated chromophore for infectious keratitis-corneal collagen cross-linking delay or replace therapeutic keratoplasty? [PDF]

World J Transplant
Antonopoulou NI, Spyropoulou MS, Papadakos SP, Papavasileiou GN, Dimakis AC.   +4 more
europepmc   +1 more source